Mental Health Prescribers’ Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region

OBJECTIVE: A wide variety of commercial pharmacogenetic (PGx) tools are available worldwide to guide treatment selection for depression based on individuals’ genetic profiles. However, the use of genetic testing to inform psychiatric care has faced challenges due to the limited training and educatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Aboelbaha, Shimaa, Zolezzi, Monica, Abdallah, Oraib, Eltorki, Yassin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239256/
https://www.ncbi.nlm.nih.gov/pubmed/37274729
http://dx.doi.org/10.2147/PGPM.S410240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239256/
https://www.ncbi.nlm.nih.gov/pubmed/37274729
http://dx.doi.org/10.2147/PGPM.S410240

Ejemplares similares